{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2005"],"condition":["Rectal Neoplasms","Colon Cancer","Rectal Cancer","Colonic Neoplasms"],"disease":["Rectal Neoplasms","Colon Cancer","Rectal Cancer","Colonic Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2022183"],"location":["Romania","Poland","United Kingdom","Serbia","India"],"study_start_month":["5"],"keyword":["Leucovorin","Fluorouracil"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Clinical Trial in Patients With Metastatic Colorectal Cancer","description":"The objective of this trial is to compare efficacy and safety of CoFactor and 5-fluorouracil (5-FU) versus leucovorin and 5-FU in treatment of metastatic colorectal cancer.","dates":{"creation":"2005-05-15"},"accession":"2022183","cross_references":{"ClinicalTrials___gov":["NCT00235898"]}}